Evolución en el diagnóstico del trastorno afectivo bipolar entre 2010 y 2015. Caldas, Colombia
DOI:
https://doi.org/10.22267/rus.212301.210Palabras clave:
Salud mental, Epidemiología, Incidencia, Prevalencia, Trastorno bipolarResumen
Introducción: En el departamento de Caldas, Colombia, se ha observado un incremento notable en el diagnóstico del trastorno afectivo bipolar (TAB), en los últimos años. Objetivo: Analizar el perfil epidemiológico del TAB en Caldas entre los años 2010 y 2015. Materiales y métodos: Se consultó la base de datos de la Dirección Territorial de Salud de Caldas y los registros del ministerio salud y protección social, para TAB. Se buscó la incidencia y la prevalencia entre los años 2010 y 2015 y se comparó la presentación de acuerdo al tipo de TAB. Resultados: La prevalencia de TAB en el departamento de Caldas el 2010 fue en general de 0,03% y para mayores de 18 años fue de 0,08%; para el 2015 en la población general, ascendió a 0,10% y para mayores de 18 años ascendió a 0,22%. La incidencia estuvo determinada por un incremento de 342 pacientes en 2010 a 969 pacientes en el 2015. Conclusiones: Se observa un marcado incremento del diagnóstico de TAB en Caldas, posiblemente debido a problemas socioculturales, causas epigenéticas o problemas de formulación tipo off-label.
Descargas
Métricas
Citas
Li H, Mukherjee D, Krishnamurthy VB, Millett C, Ryan KA, Zhang L, et al. Use of ecological momentary assessment to detect variability in mood, sleep and stress in bipolar disorder. BMC Res Notes. 2019;12(1):791. doi: 10.1186/s13104-019-4834-7.
McCormick U, Murray B, McNew B. Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. J Am Assoc Nurse Pract. 2015;27(9):530-42. doi: 10.1002/2327-6924.12275
Bruschi A, Mazza M, Camardese G, Calò S, Palumbo C, Mandelli L, et al. Psychopathological Features of Bipolar Depression: Italian Validation of the Bipolar Depression Rating Scale (I-BDRS). Front Psychol. 2018;9:1047. doi: 10.3389/fpsyg.2018.01047
Patel RS, Virani S, Saeed H, Nimmagadda S, Talukdar J, Youssef NA. Gender Differences and Comorbidities in U.S. Adults with Bipolar Disorder. Brain Sci. 2018;1;8(9):168. doi: 10.3390/brainsci8090168
Cerimele J, Fortney J, Pyne J, Curran G. Bipolar disorder in primary care: a qualitative study of clinician and patient experiences with diagnosis and treatment. Fam Pract. 2019;36(1): 32–37. doi: 10.1093/fampra/cmy019
Kim Y, Santos R, Gage FH, Marchetto MC. Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Front Cell Neurosci. 2017;11:30. doi: 10.3389/fncel.2017.00030
Leung CM, Yim CL, Yan CT, Chan CC, Xiang YT, Mak AD, et al. The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression. PLoS One. 2016;11(3):e0149752. doi: 10.1371/journal.pone.0149752
Neil ER, Winkelmann ZK, Edler JR. Defining the Term "Overuse": An Evidence-Based Review of Sport Epidemiology Literature. J Athl Train. 2018;53(3):279-281. doi: 10.4085/1062-6050-84-16
Fajardo-Gutiérrez A. Medición en epidemiología: prevalencia, incidencia, riesgo, medidas de impacto. Rev. alerg. Méx. 2017;64(1):109-120. doi: 10.29262/ram.v64i1.252
Scotti L, Franchi M, Marchesoni A, Corrao G. Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018;S0049-0172(17):30387-6. doi: doi.org/10.1016/j.semarthrit.2018.01.003
Bauer AM, Hodsdon S, Bechtel JM, Fortney JC. Applying the Principles for Digital Development: Case Study of a Smartphone App to Support Collaborative Care for Rural Patients With Posttraumatic Stress Disorder or Bipolar Disorder. J Med Internet Res. 2018;20(6):e10048. doi: 10.2196/10048
Clements C, Kapur N, Jones SH, Morriss R, Peters S. Qualitative investigation of relatives' and service users' experience of mental healthcare for suicidal behaviour in bipolar disorder. BMJ Open. 2019;9(11):e030335. doi: 10.1136/bmjopen-2019-030335
O'Rourke N, Heisel MJ, Canham SL, Sixsmith A. Predictors of suicide ideation among older adults with bipolar disorder. PLoS One. 2017;12(11):e0187632. doi: 10.1371/journal.pone.0187632
Dome P, Rihmer Z, Gonda X. Suicide Risk in Bipolar Disorder: A Brief Review. Medicina (Kaunas). 2019;55(8):403. doi: 10.3390/medicina55080403
De Oliveira L, Portugal LCL, Pereira M, Chase HW, Bertocci M, Stiffler R, et al. Predicting Bipolar Disorder Risk Factors in Distressed Young Adults From Patterns of Brain Activation to Reward: A Machine Learning Approach. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(8):726-733. doi: 10.1016/j.bpsc.2019.04.005
Organización Mundial De La Salud (OMS). Guía de intervención mhGPAP (versión 2.0): para los trastornos mentales, neurológicos y por uso de sustancias psicoactivas en nivel no especializado. Ginebra: OMS; 2016. 1. [Internet]. [cited 2019 Mar 5]. Available from: https://www.paho.org/mhgap/es/doc/GuiamhGAP.pdf?ua=1
World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research; 1993. [Internet]. [citado 10 Feb 2019]. Disponible en: World Health Organization. https://scholar.google.com/scholar?q=The+ICD-10+Classification+of+Mental+and+Behavioural+Disorders:+Diagnostic+Criteria+for+Research+World+Health+Organisation+Geneva+WHO+1993+http://www.who.int/classifications/icd/en/GRNBOOK.pdf+
Duffy A, Vandeleur C, Heffer N, Preisig M. The clinical trajectory of emerging bipolar disorder among the high-risk offspring of bipolar parents: current understanding and future considerations. Int J Bipolar Disord. 2017;5(1):37. doi: 10.1186/s40345-017-0106-4
Hunsberger JG, Chibane FL, Elkahloun AG, Henderson R, Singh R, Lawson J, et al. Novel integrative genomic tool for interrogating lithium response in bipolar disorder. Transl Psychiatry. 2015;5(2):e504. doi: 10.1038/tp.2014.139
Spoorthy MS, Chakrabarti S, Grover S. Comorbidity of bipolar and anxiety disorders: An overview of trends in research. World J Psychiatry. 2019;9(1):7-29. doi: 10.5498/wjp.v9.i1.7
Luitel NP, Garman EC, Jordans MJD, Lund C. Change in treatment coverage and barriers to mental health care among adults with depression and alcohol use disorder: a repeat cross sectional community survey in Nepal. BMC Public Health. 2019;19(1):1350. doi: 10.1186/s12889-019-7663-7
Kudo S, Tomita T, Sugawara N, Sato Y, Ishioka M, Tsuruga K, et al. The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan. Neuropsychiatr Dis Treat. 2015;11:2811-6. doi: 10.2147/NDT.S93657
Moreno-Küstner B, Martín C, Pastor L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One. 2018;13(4):e0195687. doi: 10.1371/journal.pone.0195687
Zhou X, Bi B, Zheng L, Li Z, Yang H, Song H, et al. The prevalence and risk factors for depression symptoms in a rural Chinese sample population. PLoS One. 2014;9(6):e99692. doi: 10.1371/journal.pone.0099692
Leung CM, Yim CL, Yan CT, Chan CC, Xiang YT, Mak AD, et al. The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression. PLoS One. 2016;11(3):e0149752. doi: 10.1371/journal.pone.0149752
Mirzaei M, Yasini Ardekani SM, Mirzaei M, Dehghani A. Prevalence of Depression, Anxiety and Stress among Adult Population: Results of Yazd Health Study. Iran J Psychiatry. 2019;14(2):137-146. [Internet]. [cited 2019 Aug 9]. Available from: /pmc/articles/PMC6702282/?report=abstract
Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, et al. Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011;68(3):241-51. doi: 10.1001/archgenpsychiatry.2011.12
Charara R, Forouzanfar M, Naghavi M, Moradi-Lakeh M, Afshin A, Vos T, et al. The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990-2013. PLoS One. 2017;12(1):e0169575. doi: 10.1371/journal.pone.0169575
Roos KG, Marshall SW. Definition and usage of the term "overuse injury" in the US high school and collegiate sport epidemiology literature: a systematic review. Sports Med. 2014;44(3):405-421. doi:10.1007/s40279-013-0124-z
Dolsen MR, Asarnow LD, Harvey AG. Insomnia as a transdiagnostic process in psychiatric disorders. Curr Psychiatry Rep. 2014;16(9):471. doi: 10.1007/s11920-014-0471-y
Montesinos JE. Bipolaridad. Presentación familiar. Genética del trastorno. Alcmeon. 2014;19(1):43-51. [Internet]. [citado 12 enero 2019]. Disponible en: https://www.alcmeon.com.ar/19/06_bipolaridad_montesinos.pdf
Van Wieringen JC. Secular growth changes. En Human Growth. A comprehensive treatise, 2nd ed. Vol 3: Methodology; Ecological, Genetic and Nutritional Effects of Growth, editores F. Falkner, J.M. Tanner. New York: Plenum Press;1986.
Berdasco M, Manel Esteller M. Clinical epigenetics: seizing opportunities for translation. Nature Reviews Genetics. 2019;20:109–127. doi: 10.1038/s41576-018-0074-2
Moreira ALR, Van Meter A, Genzlinger J, Youngstrom EA. Review and Meta-Analysis of Epidemiologic Studies of Adult Bipolar Disorder. J Clin Psychiatry. 2017;78(9):e1259-e1269. [Internet]. [cited 2019 may 9]. Available from: https://reference.medscape.com/medline/abstract/29188905
Scott MJ. Improving Access to Psychological Therapies (IAPT) - The Need for Radical Reform. J Health Psychol. 2018;23(9):1136-1147. doi: 10.1177/1359105318755264
Montoya-González LE, Restrepo-Bernal DP, Mejía-Montoya R, Bareno-Silva J, Sierra-Hincapié G, Torres de Galvis Y, et al. Sensibilidad y especificidad entre la Entrevista Diagnóstica Internacional Compuesta versión 3.0 (World Mental Health, CIDI) con la Evaluación Clínica Estandarizada versión I (SCID-I) en la Encuesta de Salud Mental de la ciudad de Medellín 2012. Rev colomb psiquiat. 2016;45(1):22–27. doi: 10.1016/j.rcp.2015.07.001
Faravelli C, Castellini G, Landi M, Brugnera A. Are Psychiatric Diagnoses an Obstacle for Research and Practice? Reliability, Validity and the Problem of Psychiatric Diagnoses. The Case of GAD. Clin Pract Epidemiol Ment Health. 2012;8:12-5. doi: 10.2174/1745017901208010012
Keromnes G, Motillon T, Coulon N, Berthoz A, Du Boisgueheneuc F, Wehrmann M, et al. Self-other recognition impairments in individuals with schizophrenia: a new experimental paradigm using a double mirror. NPJ Schizophr. 2018;4(1):24. doi: 10.1038/s41537-018-0065-5
Maibing CF, Pedersen CB, Benros ME, Mortensen PB, Dalsgaard S, Nordentoft M. Risk of Schizophrenia Increases After All Child and Adolescent Psychiatric Disorders: A Nationwide Study. Schizophr Bull. 2015;41(4):963-70. doi: 10.1093/schbul/sbu119
Organización Médica Colegial [Internet]. Madrid: The Association; [actualizado 20 de enero 2008; citado 12 enero 2019]. [aprox. 2 pantallas]. Disponible en: https://www.cgcom.es/sites/default/files/alegaciones_prescripcion.pdf
De Souza Gonçalves A, Moreira A, Gusmão A, Ferrarez M. Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital. Braz. J. Pharm. Sci. 2017;53(3):e00252. doi: 10.1590/s2175-97902017000300252
López J. Papel de la Farmacovigilancia en el uso off label de medicamentos [Internet]. Colombia: CIMUN, Universidad Nacional de Colombia; 2014. [citado 9 Ago 2019]. Disponible en: http://www.invima.gov.co/documents/20143/844940/1-11-Seguridad-y-vigilancia-en-el-uso-off-label.pdf/f75b59c0-efa1-53df-19f4-00c61ffc323c
